Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14550-14574

  Szekeres, Márta ^a   Tóth, Ildikó Y ^a   Illés, Erzsébet ^a   Hajdú, Angéla ^b   Zupkó, István ^c   Farkas, Katalin ^c   Oszlánczi, Gábor ^d   Tiszlavicz, László ^c   Tombácz, Etelka ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adsorption; Biocompatibility; Biomedical application; Carboxylated magnetite nanoparticles; Chemical stability; Colloidal stability; Core shell nanoparticles; Iron dissolution; Particle charge; Surface complexation

Indexed keywords

CARBOXYLIC ACID; CHEMICAL COMPOUND; CITRIC ACID; GALLIC ACID; MAGNETITE NANOPARTICLE; NANOCOATING; NANOSHELL; POLY(ACRYLIC ACID CO MALEIC ACID); POLYACRYLIC ACID; UNCLASSIFIED DRUG;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARBOXYLATION; CELL SURFACE; COLLOID; COMPLEX FORMATION; CONTROLLED STUDY; DESORPTION; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; IONIC STRENGTH; MAGNETISM; NANOCHEMISTRY; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SURFACE PROPERTY; ZETA POTENTIAL;

ACRYLIC RESINS; ADSORPTION; ANIMALS; CARBOXYLIC ACIDS; COLLOIDS; FERRIC COMPOUNDS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETITE NANOPARTICLES; PARTICLE SIZE; RATS; TAIL;

EID: 84880089559     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714550     Document Type: Article

References (66)

1. Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005 26, 3995-4021.
2. Mura, S.; Couvreur, P. Nanotheranostics for personalized medicine. Adv. Drug Deliv. Rev. 2012, 64, 1394-1416.
3. Chia, X.; Huang, D.; Zhao, Z.; Zhou, Z.; Yin, Z.; Gao, J. Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials 2012, 33, 189-206.
4. Ravindran, A.; Chandran, P.; Khan, S.S. Biofunctionalized silver nanoparticles: Advances and prospects. Colloids Surf. B 2013, 105, 342-352.
5. Ordidge, K.L.; Duffy, B.A.; Wells, J.A.; Kalber, T.L.; Janes, S.M.; Lythgoe, M.F. Imaging the paediatric lung: What does nanotechnology have to offer? Paediatr. Respir. Rev. 2012, 13, 84-88
6. Wang, M.; Thanou, M. Targeting nanoparticles to cancer. Pharmacol. Res. 2010, 62, 90-99
7. Villa, C.; Erratico, S.; Razini, P.; Fiori, F.; Rustichelli, F.; Torrente, Y.; Belicchi, M. Stem Cell Tracking by Nanotechnologies. Int. J. Mol. Sci. 2010, 11, 1070-1081.
8. Sánchez-Moreno, P.; Ortega-Vinuesa, J.L.; Martín-Rodríguez, A.; Boulaiz, H.; Marchal-Corrales, J.A.; Peula-García, J.M. Characterization of different functionalized lipidic nanocapsules as potential drug carriers. Int. J. Mol. Sci. 2012, 13, 2405-2424
9. Crommelina, D.J.A.; Florence, A.T. Towards more effective advanced drug delivery systems. Int. J. Pharm. 2013, doi:10.1016/j.ijpharm.2013.02.020.
10. Etheridge, M.L.; Campbell, S.A.; Erdman, A.G.; Haynes, C.L.; Wolf, S.M.; McCullough, J. The big picture on nanomedicine: The state of investigational and approved nanomedicine products. Nanomedicine 2013, 9, 1-14.
11. Prescription and Over-the-Counter Drug Product List 32ND Edition. Available online: http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM312738.pdf (accessed on 22 April 2013).
12. U.S. Food and Drug Administration. Drugs to be Discontinued. Available online: http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm (accessed on 22 April 2013).
13. European Medicines Agency. Questions and Answers on the Withdrawal of the Marketing Application for Sinerem, 2008. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500015294.pdf (accessed on 22 April 2013).
14. U.S. Food and Drug Administration. Available online: http://google2.fda.gov/search?q=Combidex&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*&filter=1&requiredfields=-archive%3AYes (accessed on 22 April 2013).
15. U.S. food and drug administration. Feraheme (ferumoxytol) injection. Available online: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm235636.htm (accessed on 22 April 2013).
16. NCBI. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Citrate-coated (184th variant) very small superparamagnetic iron oxide particles VSOP-C184. Available online: http://www.ncbi.nlm.nih.gov/books/NBK23512/ (accessed on 22 April 2013).
17. Bayerpharma. Trial finder-clinical trial registry and results search. Available online: http://www.bayerpharma.com/en/research-and-development/clinical-trials/trial-finder/trialfinder_detail.php?trialid=90956&search=&product=Resovist%20%28Ferucarbotran,%20BAY86%E2%80%934884%29&overall_status=&country=&phase=&condition=&results=0&trials=1&btnSubmit=submit&num=10&show=1(accessed on 22 April 2013).
18. Dufort, S.; Sancey, L.; Coll, J.-L. Physicochemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv. Drug Deliv. Rev. 2012, 64, 179-189.
19. Cornell R.M.; Schwertmann U. The Iron Oxides: Sturcutre, Properties, Reactions, Occurencies and Uses, 2nd ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2003; pp. 527-542.
20. Creixell, M.; Herrera, A.P.; Latorre-Esteves, M.; Ayala, V.; Torres-Lugo M.; Rinaldi, C. The effect of grafting method on the colloidal stability and in vitro cytotoxicity of carboxymethyl dextran coated magnetic nanoparticles. J. Mater. Chem. 2010, 20, 8539-8547.
21. Musyanovych, A.; Dausend, J.; Dass, M.; Walther, P.; Mailänder, V.; Landfester, K. Criteria impacting the cellular uptake of nanoparticles: A study emphasizing polymer type and surfactant effects. Acta Biomat. 2011, 7, 4160-4168.
22. Hajdú, A.; Illés, E.; Tombácz, E.; Borbáth, I. Surface charging, polyanionic coating and colloid stability of magnetite nanoparticles. Colloids Surf. A 2009, 347, 104-108.
23. Hajdú, A.; Szekeres, M.; Tóth, I.Y.; Bauer, R.A.; Mihály, J.; Zupkó, I.; Tombácz, E. Enhanced stability of polyacrylate-coated magnetite nanoparticles in biorelevant media. Colloids Surf. B 2012, 94, 242-249.
24. Tóth, I.Y.; Illés, E.; Bauer, R.A.; Nesztor, D.; Szekeres, M.; Zupkó, I.; Tombácz, E. Designed polyelectrolyte shell on magnetite nanocore for dilution-resistant biocompatible magnetic fluids. Langmuir 2012, 28, 16638-16646.
25. Tombácz, E.; Tóth, I.Y.; Nesztor, D.; Illés, E.; Hajdú, A.; Szekeres, M.; Vékás, L. Adsorption of organic acids on magnetite nanoparticles, pH-dependent colloidal stability and salt tolerance. Colloids Surf. A 2013, in press.
26. Tombácz, E.; Illés, E.; Hajdú, A.; Tóth, I.Y.; Bauer, R.A.; Nesztor, D.; Szekeres, M.; Zupkó, I.; Vékás, L. Colloidal stability of carboxylated iron oxide nanomagnets for biomedical use. Period. Polytech. Chem. Eng. 2013, in press.
27. Stephen, Z.R.; Kievit, F.M.; Zhang, M. Magnetite nanoparticles for medical MR imaging. Mater. Today 2011, 14, 330-338.
28. Soenen, S.J.H.; Himmelreich, U.; Nuytten, N.; Pisanic, T.R., II; Ferrari, A.; de Cuyper, M. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010, 6, 2136-2145.
29. Soenen, S.J.H.; Uwe Himmelreich, U.; Nuytten, E.; de Cuyper, M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32, 195-205.
30. Giles, C.H.; MacEwan, T.H.; Nakhwa, S.N.; Smith, D. Studies in adsorption. Part XI. A system of classification of solution adsorption isotherms. J. Chem. Soc. 1960, 4, 3973-3993.
31. Miles, W.C.; Huffstetler, P.P.; Goff, J.D.; Chen, A.Y.; Riffle, J.S.; Davis, R.M. Design of stable polyether-magnetite complexes in aqueous media: Effects of the anchor group, molecular weight, and chain density. Langmuir 2011, 27, 5456-5463.
32. Santiago-Rodríguez, L.; Lafontaine, M.M.; Castro, C.; Méndez-Vega, J.; Latorre-Esteves, M.; Juan, E.J.; Mora, E.; Torres-Lugo, M.; Rinaldi, C. Synthesis, stability, cellular uptake, and blood circulation time of carboxymethyl-inulin coated magnetic nanoparticles. J. Mater. Chem. B 2013, 1, 2807-2817.
33. n. J. Coord. Chem. 2009, 62, 1484-1491.
34. Rodríguez, E.; Fernández, G.; Ledesma, B.; Álvarez, P.; Beltrán, F.J. Photocatalytic degradation of organics in water in the presence of iron oxides: Influence of carboxylic acids, Appl. Catal. B 2009, 92, 240-249.
35. Cornell, R.M.; Schwertmann, U. The Iron Oxides: Sturcutre, Properties, Reactions, Occurencies and Uses, 2nd ed; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2003; pp. 211-213.
36. Gutteridge, J.M.C.; Mumby, S.; Lamb, N.J. Iron binding and autoreduction by citrate: Are these involved in signalling by iron regulatory protein-I? Free Radic. Res. 1998, 28, 319-322.
37. Blesa, M.A.; Weisz, A.D.; Morando, P.J.; Salfity, J.A.; Magaz, G.E.; Regazzoni, A.E. The interaction of metal oxide surfaces with complexing agents dissolved in water. Coord. Chem. Rev. 2000, 196, 31-63.
38. Waite T.D.; Morel, F.M.M. Photoreductive dissolution of colloidal iron oxide: Effect of citrate. J. Colloid Interface Sci. 1984, 102, 121-134.
39. Behdadfar, B.; Kermanpur, A.; Sadeghi-Aliabadi, H.; Morales, M.P.; Mozaffari, M. Synthesis of high intrinsic loss power aqueous ferrofluids of iron oxide nanoparticles by citric acid-assisted hydrothermal-reduction route. J. Solid State Chem. 2012, 187, 20-26.
40. Colucci, J.; Montalvo, V.; Hernandez, R.; Poullet, C. Electrochemical oxidation potential of photocatalyst reducing agents. Electrochim. Acta 1999, 44, 2507-2514.
41. Mahmoudi, M.; Simchi, A.; Milani, A.S.; Stroeve, P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J. Colloid Interface Sci. 2009, 336, 510-518.
42. Meerod, S.; Tumcharern, G.; Wichai, U.; Rutnakornpituk, M. Magnetite nanoparticles stabilized with polymeric bilayer of poly(ethylene glycol) methyl ether-poly(3-caprolactone) copolymers. Polymer 2008, 49, 3950-3956.
43. Haddad, P.S.; Martins, T.M.; D'Souza-Li, L.; Li, L.M.; Metze, K.; Adam, R.L.; Knobel, M.; Zanchet, D. Structural and morphological investigation of magnetic nanoparticles based on iron oxides for biomedical applications. Mater. Sci. Eng. C 2008, 28, 489-494.
44. Sanchez, R.D.; Rivas, J.; Vaqueiro, P.; Lopez-Quintela, M.A.; Caeiro, D. Particle size effects on magnetic properties of yttrium iron garnets prepared by a sol-gel method. J. Magn. Magn. Mater. 2002, 247, 92-98.
45. Song, M.; Zhang, Y.; Hu, S.; Song, L.; Dong, J.; Chen, Z.; Gu, N. Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles. Colloids Surf. A 2012, 408, 114-121.
46. Parvin, K.; Ma, J.; Ly, J.; Sun, X.C.; Nikles, D.E.; Sun, K.; Wang, L.M. Synthesis and magnetic properties of monodisperse Fe3O4 nanoparticles. J. Appl. Phys. 2004, 95, 7121-7123.
47. Shendruk, T.N.; Desautels, R.D.; Southern, B.W.; van Lierop, J. The effect of surface spin disorder on the magnetism of γ-Fe2O3 nanoparticle dispersions. Nanotechnology 2007, 18, doi:10.1088/0957-4484/18/45/455704.
48. Soenen, S.J.; Nuytten, N.; Himmelreich, U.; de Cuyper, M. Intracellular iron oxide nanoparticle coating stability determines nanoparticle usability and cell functionality. Drug Discov. Today 2010, 15, 1082.
49. Safi, M.; Courtois, J.; Seigneuret, M.; Conjeaud, H.; Berret, J.-F. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 2011, 32, 9353-9363.
50. Lartigue, L.; Wilhelm, C.; Servais, J.; Factor, C.; Dencausse, A.; Bacri, J.-C.; Luciani, N.; Gazeau, F. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: Impact on macrophage uptake. ACS Nano 2012, 6, 2665-2678.
51. Jedlovszky-Hajdú, A.; Bombelli, F.B.; Monopoli, M.P.; Tombácz, E.; Dawson, K.A. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir 2012, 28, 14983-14991.
52. Jackson, S.P. The growing complexity of platelet aggregation. Blood 2007, 109, 5087-5095.
53. Jung, S.M.; Kinoshita, K.; Tanoue, K.; Isohisa, I.; Yamazaki, H. Role of surface negative charge in platelet function related to the hyperreactive state in estrogen-treated prostatic carcinoma. Thromb. Haemost. 1982, 47, 203-209.
54. Grøttum, K.A.; Jørgensen, L.; Jeremic, M. Decrease in platelet surface charge during phagocytosis of polystyrene latex particles or thorium dioxide. Scand. J. Haematol. 1972, 9, 83-96.
55. Grant, R.A.; Zucker, M.B. EDTA-induced increase in platelet surface charge associated with the loss of aggregability. Assessment by partition in aqueous two-phase polymer systems and electrophoretic mobility. Blood 1978, 52, 515-523.
56. Smyth, S.S.; Whiteheart, S.; Italiano, J.E., Jr.; Coller, B.S. Platelet Morphology, Biochemistry & Function. In Williams Hematology, 8th ed.; The McGraw-Hill Companies, Inc.: New York, NY, USA, 2010; pp. 1735-1814.
57. Bhattarai, S.R.; Kc, R.B.; Kim, S.Y.; Sharma, M.; Khil, M.S.; Hwang, P.H.; Chung, G.H.; Kim, H.Y. N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. J. Nanobiotechnol. 2008, 6, doi:10.1186/1477-3155-6-1.
58. Ruiz, A.; Salas, G.; Calero, M.; Hernández, Y.; Villanueva, A.; Herranz, F.; Veintemillas-Verdaguer, S.; Martínez, E.; Barber, D.F.; Morales, M.P. Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents. Acta Biomater. 2013, 9, 6421-6430.
59. Alexiou, C.; Jurgons, R.; Seliger, C.; Brunke, O.; Iro, H.; Odenbach, S. Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting. Anticancer Res. 2007, 27, 2019-2022.
60. Janic, B.; Rad, A.M.; Jordan, E.K.; Iskander, A.S.M.; Ali, M.M.; Varma, N.R.S.; Frank, J.A.; Arbab, A.S. Optimization and validation of FePro cell labeling method. PLoS One 2009, 4, doi:10.1371/journal.pone.0005873.
61. Misri, R.; Meier, D.; Yung, A.C.; Kozlowski, P.; Häfeli, U.O. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomedicine 2012, 8, 1007-1016.
62. Illés, E.; Tombácz, E. The effect of humic acid adsorption on pH-dependent surface charging and aggregation of magnetite nanoparticles. J. Colloid Interface Sci. 2006, 295, 115-123.
63. Vékás, L.; Bica, D.; Marinica, O. Magnetic nanofluids stabilized with various chain length surfactants. Rom. Rep. Phys. 2006, 58, 217-228.
64. Bica, D.; Vékás, L.; Avdeev, M.V.; Marinica, O.; Socoliuc, V.; Balasoiu, M.; Garamus, V.M. Sterically stabilized water based magnetic fluids: Synthesis, structure and properties. J. Magn. Magn. Mater. 2007, 311, 17-21.
65. Tombácz, E.; Illés, E.; Majzik, A.; Hajdú, A.; Rideg, N.; Szekeres, M. Ageing in the inorganic nanoworld: Example of magnetite nanoparticles in aqueous medium. Croat. Chem. Acta 2007, 80, 503-515.
66. Tombácz, E.; Hajdú, A.; Illés, E.; László, K.; Garberoglio, G.; Jedlovszky, P. Water in contact with magnetite nanoparticles, as seen from experiments and computer simulations. Langmuir 2009, 25, 13007-13014.